RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
about
The inherited bone marrow failure syndromesOverexpression of Rad51C splice variants in colorectal tumorsThe rice RAD51C gene is required for the meiosis of both female and male gametocytes and the DNA repair of somatic cellsMycobacterium tuberculosis DinG is a structure-specific helicase that unwinds G4 DNA: implications for targeting G4 DNA as a novel therapeutic approach.C. elegans ring finger protein RNF-113 is involved in interstrand DNA crosslink repair and interacts with a RAD51C homolog.RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines.Pathways of resistance to thymineless death in Escherichia coli and the function of UvrD.Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech RepublicDistinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro.Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger SequencingCell cycle control in acute myeloid leukemia.Ovarian cancer: in search of better marker systems based on DNA repair defectsMammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart.Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management.TNF-α signaling in Fanconi anemia.Stress and DNA repair biology of the Fanconi anemia pathwayTherapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.Mycobacterium tuberculosis RecG protein but not RuvAB or RecA protein is efficient at remodeling the stalled replication forks: implications for multiple mechanisms of replication restart in mycobacteriaAn Overview of the Molecular Mechanisms of Recombinational DNA Repair.Trans-dichlorooxovandium (IV) complex as a novel photoinducible DNA interstrand crosslinker for cancer therapy.The Shu complex is a conserved regulator of homologous recombination.ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair.BRCA2 is epistatic to the RAD51 paralogs in response to DNA damageDiscovery of mutations in homologous recombination genes in African-American women with breast cancer.Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.FANCJ helicase controls the balance between short- and long-tract gene conversions between sister chromatids.Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancerDNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells.Germline mutations in RAD51C in Jewish high cancer risk families.Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.RAD51C/XRCC3 Facilitates Mitochondrial DNA Replication and Maintains Integrity of the Mitochondrial Genome.
P2860
Q26999046-6C192E0B-7A80-4E9C-99B3-C8C0679D5CB6Q28256773-2C401F64-A412-49CD-9AF4-C26B23D9A707Q28272384-3B3FFB23-6753-4949-BB42-855E97FB6757Q34139085-F59E7900-5D5C-4D8C-B34C-E8068C3F373FQ34337102-067E7270-D13E-4841-A771-C87994B6A76BQ34425236-CF71136B-CE95-4368-8579-7902BFD0A2ACQ35221548-44464F69-4AAA-498D-BBA0-149C7D47DA9AQ35657899-4183941D-AB27-4202-8C4C-4CD71F8DA7F5Q35728414-ADE8B60F-6F94-4622-9D96-ECA7D40C764FQ35789619-CD0944D5-B32D-4203-9060-9DC16790A7FEQ36072260-B70E1425-F47A-4E74-BCCB-16B9A0663DCEQ36206479-B2138B73-170F-41CD-9F34-73D12D4251A0Q36589947-F27309F6-D71E-4B5B-8A6B-2A626A100E4EQ36676526-F82398A2-6E39-4DC1-90ED-CDABE7E45287Q37128839-CDCB0D6A-7CA7-4558-AC1E-6344E4A91C61Q38013077-282DD2B4-38BF-4252-BB19-8B6D070C5A36Q38124483-51667FAF-0267-447A-8317-64059A5BCB8AQ38252562-3C408D50-5CEF-4885-8BE3-9A81B0EA4CC5Q38268221-92316EE7-B6AD-4727-93B5-4ECB43996B7EQ38297065-329B0D42-A11F-45B2-845C-5EFB0231B734Q38622583-53585F4A-B92A-4FF1-8B87-1A46A6EF1074Q38810986-05605FB0-B410-476B-AE54-B0D656C2CE7DQ38945021-A8BCB48D-4D3F-4DFB-AA7E-4068C5B137BDQ39189002-6231BDC6-7B83-47BE-A122-3B58A40F106EQ39199056-ED418B72-2034-4140-9B9D-67BEFEE1EBEDQ40060771-879E9A89-D743-426B-8511-C19BB1B15F71Q41133980-637FB6D7-2C69-40B0-977C-07848A5E5EC1Q41628920-F521B543-F10C-49E4-8AF1-39FB66C2F477Q42021055-4CEC4E41-E5D1-4847-942A-FB18AF278928Q42374449-0349EDB0-C877-4948-B1E8-72ACE456C6E7Q42953216-C0E3A95D-3E95-4876-B35C-33B67964C7CFQ44358800-04D1EA4A-7E7C-46C0-8565-42675817499FQ47141035-A88FE45F-AE69-4FE7-BA4F-5DD025B0F737Q49153890-22E5C345-8D46-4737-8BA8-9AAE7495249DQ51045691-4315A715-54FE-4432-912A-486BC46CFD26Q51690290-0A8804EB-7615-4BC2-A50E-D5B4EFCC8A29Q51782532-C5D28313-AA0A-4FB9-A2A4-04D1307DFDF9
P2860
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@en
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@nl
type
label
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@en
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@nl
prefLabel
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@en
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
@en
P2093
Ganesh Nagaraju
Kumar Somyajit
Shreelakshmi Subramanya
P2860
P304
P356
10.1093/CARCIN/BGQ210
P407
P5008
P577
2010-10-15T00:00:00Z
2010-12-01T00:00:00Z